A nomogram can estimate the chance of salvage for children with relapsed nonmetastatic rhabdomyosarcoma to guide therapy.
May support salvage probability estimation to guide therapy in relapsed pediatric rhabdomyosarcoma; leaves open external validation before clinical adoption.
Some children with relapsed RMS remain curable. It is now possible to estimate the chance of salvage for individual children to direct therapy appropriately toward cure, use of experimental therapies, and/or palliation.
No takes yet. Share an insight, caveat, or question.
Chisholm et al. (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: